Michael Rabinowitz

Mr. Rabinowitz serves as Chief Commercial Officer of Oramed Pharmaceuticals. He has a deep and broad track record of success from over 25 years in the life sciences serving in marketing, sales, business development, and financial leadership roles in the U.S. and globally.

Prior to his current position, Mr. Rabinowitz spent over two decades at Merck in various leadership roles. At Merck, he launched and marketed products in over 30 countries across several disease areas, including launching billion-dollar oral agents in diabetes and managing a global business. He helped build disease portfolios through licensing and acquisition, as well as establishing global strategic partnerships with healthcare leaders and innovators. He also served as the Head of Investor Relations at Merck.

Mr. Rabinowitz received his bachelor’s degree summa cum laude from Northwestern University and his master’s degree from the Carlson School of Management at the University of Minnesota. He has since attended executive classes at the Harvard Business School and the Wharton School of the University of Pennsylvania.